In another study, overexpression of lymphoid enhancer-binding factor 1 (LEF1) by the CRISPR/Cas9 system in GD2-CAR NKT cells showed superior control in neuroblastoma xenograft mouse models [149]. Here, LEF1 is linked to neuroblastoma.